Accomplished DMPK Project Representative and Subject Matter Expert with a combined 7 years of industry experience. Proven track record of spearheading 2 oncology projects through candidate nomination and globally leading CYP Induction assay support for the pipeline.
Overview
7
7
years of professional experience
Work History
Sr. Scientist II
AbbVie
South San Francisco, California
08.2022 - Current
Lead DMPK project representative on two oncology projects: Independently spearheaded the transition of two oncology programs through Candidate Nomination/Selection
Key project representative activities include- Deep-dive into in vitro ADME data, preclinical in vivo PK data, designing efficacy studies, human PK and dose projections, guidance on safety/tox studies to establish optimal safety margins
Lead for CYP Induction: Successfully supported over 20 small molecule/ADC programs from multiple disease areas through Candidate Nomination/Selection
Lead author on regulatory IND reports: Authored CYP Induction section of over 20 IND reports
Introduced methodologies that would improve assay efficiency, generated data that would support the preference to use certain DDI models over others in the established workflow
Sr. Scientist I
AbbVie
South San Francisco, California
03.2019 - 07.2022
Designed and conducted multiple in vitro ADME assays to support early-stage discovery
Global Lead for discovery stage MetID assay in s9 subcellular fractions
Education
Research Scientist/Postdoc Training - Pharmaceutical Sciences
University of Pittsburgh
Pittsburgh, PA
03-2016
Postdoc Associate - Pharmaceutical Sciences
Virginia Commonwealth University
Richmond, Virginia, VA
06-2013
Ph.D. - Medicinal Chemistry
University of Kansas
Lawrence, KS
05-2013
Master of Science - Medicinal Chemistry
NIPER
Mohali, India
07-2007
Skills
DMPK Project Representative
SME (CYP Induction)
In vitro/in vivo ADME/PK analysis
Regulatory IND reports
Preclinical drug development
Efficacy/Tox study design
Cross-functional collaboration
Team leadership
Volunteer Experience
Reviewer, Molecular Pharmaceutics, Cancer Chemo. and Pharm. and multiple relevant peer reviewed scientific journals